2023-09-05 13:27:00
The number of people with diabetes in France grew steadily between 2000 and 2009. The rate grew faster than expected because in 2009 it was estimated that more than 3.5 million people had diabetes, a figure that would normally be expected for the year 2016.
The distribution of diabetes cases is not equal between men and women. Men are more affected.
Geographically, the overseas territories and northern France are the most affected by diabetes. Thus, the prevalence can reach 6.23% in Hauts-de-France, 9.12% in Guadeloupe and 10.21% on Reunion Island.
Type 2 diabetes: the causes of its increase
90% of people with diabetes have type 2 diabetes which is characterized by a long-lasting excess of the concentration of glucose in the blood.
This type of diabetes is on the rise for several reasons. The population is aging and screening is expanding. However, our way of life is an undeniable factor in the increase in the number of cases. Thus, overweight, obesity, lack of physical activity, sedentary lifestyle are all impacting elements.
The health risks associated with diabetes
Diabetes is not without long-term consequences on the body since the continuous hyperglycemia it causes can cause: myocardial infarction and heart failure, retinopathy (eyes), kidney failure, stroke, arteriopathy and neuropathy of the lower limbs. Being able to predict this type of pathology would be a good thing for patients.
A study of 2,600 people with type 2 diabetes
A team of researchers whose study was published in the journal Circulation of the American Heart Association, discovered that certain biomarkers present in the blood make it possible to predict the development of heart and kidney disorders.
So, blood data from 2,627 patients with type 2 diabetes and kidney disease were analyzed. The effects of canagliflozin (a treatment used in type 2 diabetes) on the concentrations of 4 biomarkers, the prognostic value of each biomarker on different levels of risk of renal problems and on the risk of death from renal or cardiovascular causes have been studied by the team.
A blood test to predict the risk of heart or kidney disease
The results of the study led Dr. James Januzzi, professor of medicine at Harvard Medical School and cardiologist at Massachusetts General Hospital, lead author of the study, to state that: elevated levels of certain biomarkers are indicators of heart and kidney complications and may help predict future risk of disease progression”. Canagliflozin treatment not only lowered levels of these biomarkers but also reduced the risk of hospitalization for heart failure and other cardiac complications in the highest-risk participants. »
1694089628
#blood #test #predict #risk #heart #kidney #disease
